Clinical trial
Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics…
NCT00235690 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00235690 |
|---|---|
| Title | Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036) |
| Official title | Pharmacokinetics and Pharmacodynamics of Intravenous Colistin- Pilot Study |
| Lead sponsor | University of Pittsburgh, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Bacteremia, Pseudomonas Infections |
| Intervention type | Other, Procedure |
| Interventions | Blood draws, Blood draw |
| Enrollment | 10 |
| Start date | Jun 1, 2008 |
| Primary completion | Aug 1, 2015 |
| Completion | Aug 1, 2015 |
| First posted | Oct 10, 2005 |
| Last update posted | Dec 17, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: